ENST00000511181.5:c.-376-4189delC
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The ENST00000511181.5(HEXB):c.-376-4189delC variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.55 ( 23250 hom., cov: 0)
Exomes 𝑓: 0.56 ( 151750 hom. )
Consequence
HEXB
ENST00000511181.5 intron
ENST00000511181.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.00
Genes affected
HEXB (HGNC:4879): (hexosaminidase subunit beta) Hexosaminidase B is the beta subunit of the lysosomal enzyme beta-hexosaminidase that, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Beta-hexosaminidase is composed of two subunits, alpha and beta, which are encoded by separate genes. Both beta-hexosaminidase alpha and beta subunits are members of family 20 of glycosyl hydrolases. Mutations in the alpha or beta subunit genes lead to an accumulation of GM2 ganglioside in neurons and neurodegenerative disorders termed the GM2 gangliosidoses. Beta subunit gene mutations lead to Sandhoff disease (GM2-gangliosidosis type II). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 5-74685138-GC-G is Benign according to our data. Variant chr5-74685138-GC-G is described in ClinVar as [Benign]. Clinvar id is 369507.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.567 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.550 AC: 83244AN: 151264Hom.: 23232 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
83244
AN:
151264
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.563 AC: 530677AN: 943042Hom.: 151750 Cov.: 0 AF XY: 0.562 AC XY: 262327AN XY: 466632 show subpopulations
GnomAD4 exome
AF:
AC:
530677
AN:
943042
Hom.:
Cov.:
0
AF XY:
AC XY:
262327
AN XY:
466632
show subpopulations
African (AFR)
AF:
AC:
10268
AN:
18428
American (AMR)
AF:
AC:
4893
AN:
13048
Ashkenazi Jewish (ASJ)
AF:
AC:
8919
AN:
15464
East Asian (EAS)
AF:
AC:
13272
AN:
27838
South Asian (SAS)
AF:
AC:
29121
AN:
51448
European-Finnish (FIN)
AF:
AC:
18391
AN:
29542
Middle Eastern (MID)
AF:
AC:
1700
AN:
2890
European-Non Finnish (NFE)
AF:
AC:
421089
AN:
742828
Other (OTH)
AF:
AC:
23024
AN:
41556
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
11883
23766
35650
47533
59416
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.550 AC: 83297AN: 151384Hom.: 23250 Cov.: 0 AF XY: 0.549 AC XY: 40611AN XY: 73934 show subpopulations
GnomAD4 genome
AF:
AC:
83297
AN:
151384
Hom.:
Cov.:
0
AF XY:
AC XY:
40611
AN XY:
73934
show subpopulations
African (AFR)
AF:
AC:
23034
AN:
41274
American (AMR)
AF:
AC:
6285
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
AC:
2001
AN:
3468
East Asian (EAS)
AF:
AC:
2332
AN:
5064
South Asian (SAS)
AF:
AC:
2648
AN:
4798
European-Finnish (FIN)
AF:
AC:
6512
AN:
10472
Middle Eastern (MID)
AF:
AC:
170
AN:
294
European-Non Finnish (NFE)
AF:
AC:
38742
AN:
67748
Other (OTH)
AF:
AC:
1160
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1883
3766
5649
7532
9415
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
1634
AN:
3472
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Sandhoff disease Benign:3
Aug 28, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.